PD-L1 downregulation indicates reduced reliance on the PD-1/PD-L1 axis for immune escape, whereas HLA-I downregulation impairs antigen presentation, rendering CD8+ T cells unable to recognize tumor cells. This evidence concerns the gene CD274 and neoplasm.